Publication
2017
Estimated Economic Impact of Vaccinations in 73 LMIC, 2001-2020
This analysis estimates the economic impact likely to be achieved by efforts to vaccinate against 10 …
This analysis estimates the economic impact likely to be achieved by efforts to vaccinate against 10 vaccine-preventable diseases between 2001 and 2020 in 73 low- and middle-income countries largely supported by Gavi, the Vaccine Alliance. The authors used health impact models to estimate the economic impact of achieving forecasted coverages for vaccination against Haemophilus influenzae type b, hepatitis B, human papillomavirus, Japanese encephalitis, measles, Neisseria meningitidis serogroup A, rotavirus, rubella, Streptococcus pneumoniae and yellow fever. In…
Health Outcomes
|
Economics/Finance
|
Latin America & Caribbean
|
Health Systems
|
State-Transition
|
Dynamic Transmission
|
Microsimulation
|
Cost-Effectiveness Analysis
|
Infectious Diseases
|
Child/Nutrition
|
Health/Medicine
|
Sub-Saharan Africa
|
Middle East & North Africa
|
Asia & Pacific